GLUCK FREDERICK W

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$710,427.46
Insider Sells Quantity
11
Insider Sells Sum
$3.98M

Insider Activity of GLUCK FREDERICK W

The largest purchase of all time was on 2015-10-14 and amounted to 30000 shares of CytomX Therapeutics, Inc. for $360,000.

The largest sale of all time was on 2018-03-02 and amounted to 32362 shares of CytomX Therapeutics, Inc. for $970,931.

Biography of GLUCK FREDERICK W

No biography is available at this moment.

2018-03-26SaleCytomX Therapeutics, Inc.
CTMX
director
10,000
0.0254%
$31.93$319,283-41.71%
2018-03-02SaleCytomX Therapeutics, Inc.
CTMX
director
32,362
0.0756%
$30.00$970,931-32.69%
2018-02-28SaleCytomX Therapeutics, Inc.
CTMX
director
7,638
0.02%
$30.00$229,140-24.3%
2018-01-05SaleCytomX Therapeutics, Inc.
CTMX
director
20,000
0.052%
$25.01$500,156-1.69%
2017-12-26SaleCytomX Therapeutics, Inc.
CTMX
director
10,000
0.0262%
$22.29$222,851+11.12%
2017-10-04SaleCytomX Therapeutics, Inc.
CTMX
director
20,000
0.0544%
$24.27$485,360+5.89%
2017-09-26SaleCytomX Therapeutics, Inc.
CTMX
director
10,000
0.027%
$17.30$172,952+40.92%
2017-06-26SaleCytomX Therapeutics, Inc.
CTMX
director
10,000
0.0267%
$14.61$146,100+48.15%
2015-10-14PurchaseCytomX Therapeutics, Inc.
CTMX
director
30,000
0.0753%
$12.00$360,000-3.85%
2010-09-08SaleAmgen Inc.
AMGN
director
800
<0.0001%
$52.36$41,888+4.68%
2010-08-26SaleAmgen Inc.
AMGN
director
800
<0.0001%
$51.76$41,404+8.52%
2009-01-27SaleAmgen Inc.
AMGN
director
16,000
0.0016%
$53.29$852,621+5.91%
2006-02-17PurchaseAmgen Inc.
AMGN
director
4,705
0.0004%
$74.48$350,427-6.84%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.